Showing results (551-560 of 624) with videos related to
Sort By:
Pageof 63
Molecular Cancer Research : MCR|May 3, 2014
FGFR3 translocations in bladder cancer: differential sensitivity to HSP90 inhibition based on drug metabolismJaime Acquaviva, Suqin He, Chaohua Zhang, et al.Blood|December 23, 1999
A prospective study of residual-disease monitoring of the ALL1/AF4 transcript in patients with t(4;11) acute lymphoblastic leukemiaG Cimino, L Elia, M C Rapanotti, et al.The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Acute leukemia following a previous malignancy: do acute lymphoid leukemia and acute myeloid leukemia have common risk factors?L Pagano, A Pulsoni, M E Tosti, et al.Optics Express|July 21, 2015
Sub-Nyquist field trial using time frequency packed DP-QPSK super-channel within fixed ITU-T gridL Potì, G Meloni, G Berrettini, et al.Journal of Biological Regulators and Homeostatic Agents|April 23, 2014
Immunomodulating treatment with low dose interleukin-4, interleukin-10 and interleukin-11 in psoriasis vulgarisM L Roberti, L Ricottini, A Capponi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2013
Preclinical activity profile and therapeutic efficacy of the HSP90 inhibitor ganetespib in triple-negative breast cancerDavid A Proia, Chaohua Zhang, Manuel Sequeira, et al.British Journal of Haematology|September 30, 1998
The influence of HLA-matched sibling donor availability on treatment outcome for patients with AML: an analysis of the AML 8A study of the EORTC Leukaemia Cooperative Group and GIMEMA. European Organization for Research and Treatment of Cancer. Gruppo Italiano Malattie Ematologiche Maligne dell'AdultoS Keating, T de Witte, S Suciu, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 7, 2018
Ganetespib limits ciliation and cystogenesis in autosomal-dominant polycystic kidney disease (ADPKD)Anna S Nikonova, Alexander Y Deneka, Anna A Kiseleva, et al.Leukemia|August 30, 2002
Chemotherapy only compared to chemotherapy followed by transplantation in high risk myelodysplastic syndrome and secondary acute myeloid leukemia; two parallel studies adjusted for various prognostic factorsM Oosterveld, P Muus, S Suciu, et al.Bone Marrow Transplantation|August 26, 1998
Umbilical cord blood transplant from HLA-mismatched unrelated donor in high-risk leukemiaW Arcese, A P Iori, M Screnci, et al.Pageof 63